Taipan Resources (TAIPF) 0.0518 $TAIPF Taipan Closes

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Taipan Resources (TAIPF) 0.0518 $TAIPF

Taipan Closes Agreement to Buy a 25% Working Interest in Oil and Gas Leases in Texas Panhandle
ACCESSWIRE - Thu Jun 02, 7:13AM CDT
VANCOUVER, BC / ACCESSWIRE / June 2, 2016 / Taipan Resources Inc. (TSXV: TPN) ("Taipan" or the "Company" is pleased to announce that it has closed its acquisition of a twenty five percent (25%) working interest in in fifty seven (57) oil and gas leases covering 7,314 acres located in the bifurcated Texas Panhandle (the "Transaction". Taipan purchased its 25% working interest from Ponderosa Energy, LLC ("Ponderosa" for the sum of US$500,000. In addition, Taipan has undertaken to pay Ponderosa's seventy five percent (75%) working interest share of approved costs incurred in compliance with the terms of the joint operating agreement ("JOA" that governs the relationship between the Company and Ponderosa in respect of the Leases, subject to a total cap of US$750,000. The Transaction is an arm's length transaction and no finder's fee is payable in connection with the Transaction.
TPN.VN: 0.075 (-0.010)

Taipan Enters into an Agreement to Buy a 25% Working Interest in Oil & Gas Leases in Texas Panhandle
ACCESSWIRE - Mon May 09, 11:35AM CDT
VANCOUVER, BC / ACCESSWIRE / May 9, 2016 / Taipan Resources Inc. (TSXV: TPN) ("Taipan" or the "Company" is pleased to announce that it has entered into a Working Interest Assignment Agreement with Ponderosa Engergy, LLC ("Ponderosa" to purchase a twenty five percent (25%) working interest in Ponderosa's 100% working interest in fifty seven (57) oil and gas leases covering 7,314 acres located in the bifurcated Texas Panhandle (the "Transaction". Taipan will purchase its 25% working interest for the sum of US$500,000 (the "Consideration". In addition, Taipan will undertake to pay Ponderosa's working interest share (75%) of approved costs incurred in compliance with the terms of the joint operating agreement ("JOA" that will govern the relationship between the Company and Ponderosa in respect of the Leases, subject to a total cap of US$750,000. The closing of the transaction is subject to TSX Venture Exchange approval, satisfactory due diligence by Taipan and execution of the JOA.
TPN.VN: 0.075 (-0.010)

Taipan Announces Election of a New Board of Directors and Appoints New Officers
ACCESSWIRE - Thu Apr 07, 5:00PM CDT
VANCOUVER, BC / ACCESSWIRE / April 7, 2016 / Taipan Resources Inc. (TSXV: TPN) ("Taipan" or the "Company" is pleased to announce at its annual general meeting of shareholders held on Tuesday April 5, 2016 that the shareholders have elected a new board of directors for the Company. The outgoing board of directors cease to hold office as of April 05, 2016 and the newly elected two (2) directors, namely Mr. John Cumming and Mr. Kevin Ma, together with existing director Joel Dumaresq will form the new board of the Company.
TPN.VN: 0.075 (-0.010)

Taipan Resources Inc. Cancels Acquisition of Interest in Salam Block, Pakistan
ACCESSWIRE - Mon Dec 14, 7:43AM CST
VANCOUVER, BC / ACCESSWIRE / December 14, 2015 / Taipan Resources Inc. (TSXV: TPN) (OTCQX: TAIPF) ("Taipan" or the "Company" announces that it will not be proceeding with the proposed acquisition of a 50% interest in BLOCK 2769-13 (the "Salam Block" from Petroleum Exploration (PVT) Ltd., which was the subject of the non-binding letter of intent described in Taipan's press release of August 10, 2015.
TPN.VN: 0.075 (-0.010)

Taipan Resources Inc. Shares to Re-commence Trading on TSXV
ACCESSWIRE - Tue Sep 22, 5:54PM CDT
VANCOUVER, BC / ACCESSWIRE / September 22, 2015 / Taipan Resources Inc. (TSXV: TPN) ("Taipan" or the "Company" is pleased to announce that, further to the Company's news release dated September 17, 2015 announcing the consolidation of its issued and outstanding common shares on the basis of one new common share for every ten common shares then issued and outstanding, the Company's common shares will re-commence trading on the TSX Venture Exchange on a consolidated basis at the open of markets on Wednesday, September 23, 2015. On a post-consolidation basis, there are approximately 10,548,631 common shares issued and outstanding. The Company's name and trading symbol will remain the same.
TPN.VN: 0.075 (-0.010)

IIROC Trade Resumption - Taipan Resources Inc.
Newsfile Corp - Tue Sep 22, 3:11PM CDT
Trading resumes in:

Taipan Resources Inc. Announces Effective Date of Share Consolidation
ACCESSWIRE - Thu Sep 17, 7:56PM CDT
VANCOUVER, BC / ACCESSWIRE / September 17, 2015 / Taipan Resources Inc. (TSXV: TPN) ("Taipan" or the "Company" is pleased to announce that it has received the approval of the TSX Venture Exchange to the consolidation of its issued and outstanding common shares on the basis of one new common share for every ten common shares currently issued and outstanding.
TPN.VN: 0.075 (-0.010)

Taipan Resources Inc. Announces Execution of Letter of Intent to Acquire an Interest in Block 2769-13 (The Salam Block), Pakistan
ACCESSWIRE - Mon Aug 10, 2:40PM CDT
VANCOUVER, BC / ACCESSWIRE / August 10, 2015 / Taipan Resources Inc. (TSXV: TPN) (PINKSHEETS: TAIPF) ("Taipan" or the "Company" announces that it has entered into a non-binding letter of intent dated July 29, 2015 (the "Letter of Intent" with Petroleum Exploration Limited ("PEL" to acquire a 50% interest in PEL's Block 2769-13 (Salam) (the "Interest" located in the Jacobabad and Ghotki Districts of the Sindh Province in Pakistan (the "Transaction".
TPN.VN: 0.075 (-0.010)

IIROC Trade Halt - Taipan Resources Inc.
Newsfile Corp - Wed Jul 29, 11:08AM CDT
The following issues have been halted by IIROC:

Taipan Provides Update On Kenya Based Exploration Blocks
ACCESSWIRE - Thu May 28, 4:51PM CDT
NAIROBI, KENYA / ACCESSWIRE / May 28, 2015 / Taipan Resources Inc. (TSXV: TPN) (OTCQX: TAIPF) ("Taipan", "the Company". Following completion of operations on the Badada-1 well on Block 2B, Kenya, Premier Oil have exercised their right to withdraw from the license effective April 30th 2015. As a result, the working interests for Taipan through its Kenya-based subsidiary Lion Petroleum ("Lion" and Tower Resources plc ("Tower" in the Block will be adjusted on a pro-rata basis (Lion 66.66%, Tower 33.34%) for the remaining approximately six months of the current licence phase (unless otherwise agreed).
TPN.VN: 0.075 (-0.010)

Taipan Commences Arbitration Against EAX/Afren
Marketwire Canada - Mon Feb 09, 8:00AM CST
Taipan Resources Inc. (TSX VENTURE:TPN)(OTCQX:TAIPF) ("Taipan", "the Company", announced that the Company's Kenya based subsidiary Lion Petroleum Corp ("Lion" has commenced an arbitration action against East African Exploration (Kenya) Limited ("EAX", a wholly owned subsidiary of Afren Plc. This action has been filed in response to certain breaches to the Joint Operating Agreement ("JOA" signed between EAX and Lion in respect of Block 1.
TPN.VN: 0.075 (-0.010)

Badada-1 Well Drilling Update
Marketwired - Wed Feb 04, 8:04AM CST
Taipan Resources Inc. (TSX VENTURE: TPN)(OTCQX: TAIPF) ("Taipan", "the Company", through its Kenya-based subsidiary Lion Petroleum ("Lion", is pleased to provide the following update on drilling operations for the Badada-1 well, Block-2B, onshore Kenya.
TPN.VN: 0.075 (-0.010)

Parkit Appoints Joel Dumaresq to Board of Directors
Marketwired - Thu Jan 29, 8:16AM CST
Parkit Enterprise Inc. (TSX VENTURE: PKT)(OTCQX: PKTEF) is pleased to announce the appointment of Joel Dumaresq to its Board of Directors.
PKT.VN: 0.305 (-0.015)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading